NEUP · NASDAQ
Neuphoria Therapeutics (NEUP) Stock Price & Fundamentals
Neuphoria Therapeutics (NEUP) closed at $503.09 on Oct 9, 2026, down 0.65% from the previous close of $506.38.
Share price, past year
1Y −14.09%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $503.09 |
| Sep 30, 2026 | $495.74 |
| Aug 31, 2026 | $475.10 |
| Jul 31, 2026 | $503.20 |
| Jun 30, 2026 | $515.61 |
| May 29, 2026 | $524.09 |
| Apr 30, 2026 | $548.96 |
| Mar 31, 2026 | $544.39 |
| Feb 27, 2026 | $551.46 |
| Jan 30, 2026 | $582.60 |
| Dec 31, 2025 | $581.34 |
| Nov 28, 2025 | $604.98 |
| Oct 31, 2025 | $587.13 |
Key statistics
- Market cap
- $2.72B
- P/E (TTM)
- —
- EPS (TTM)
- −$3.06
- Revenue (TTM)
- —
- Net income (TTM)
- −$13.45M
- Shares outstanding
- 5.4M
- Dividend yield
- —
- 52-week range
- $471.94 – $622.93
Neuphoria Therapeutics's market cap is $2.72B, based on a share price of $503.09 and 5.4M shares outstanding as of Jun 30, 2026.
Financials
Neuphoria Therapeutics reported revenue of $1.17M for fiscal 2026, down 92.50% from fiscal 2025.
Neuphoria Therapeutics reported a net loss of $13.45M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $1.17M | −92.5% | −$13.45M | −1,145.7% | −$3.06 | — |
| FY2025ended Jun 30, 2025 | $15.65M | — | −$369.63K | −2.4% | −$0.23 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2025ended Mar 31, 2025 | $15.00M | $11.26M | $6.55 |
| Q2 FY2025ended Dec 31, 2024 | $662.72K | −$1.94M | −$1.79 |
Company profile
- Name
- Neuphoria Therapeutics Inc.
- Ticker
- NEUP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 100 Summit Dr, Burlington, MA 01803
- Incorporated in
- C3
- Fiscal year ends
- June
- SEC CIK
- 0001191070
Recent SEC filings
- Sep 18, 2026
- Jul 24, 2026
- May 26, 2026
- May 15, 2026
- Feb 17, 2026
- Jan 8, 2026
- Dec 18, 2025
- Dec 17, 2025
Frequently asked questions
What is Neuphoria Therapeutics's stock price?
Neuphoria Therapeutics (NEUP) closed at $503.09 on Oct 9, 2026, down 0.65% from the previous close of $506.38.
What is Neuphoria Therapeutics's market cap?
Neuphoria Therapeutics's market cap is $2.72B, based on a share price of $503.09 and 5.4M shares outstanding as of Jun 30, 2026.
How much revenue does Neuphoria Therapeutics make?
Neuphoria Therapeutics reported revenue of $1.17M for fiscal 2026, down 92.50% from fiscal 2025.
Does Neuphoria Therapeutics pay a dividend?
Neuphoria Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Neuphoria Therapeutics Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures